Chercheur

Samir MESSAOUDI studied chemistry (DEA) at Blaise Pascal University (Clermont Ferrand, France) and completed his PhD in 2004 in the group of Prof. Michelle Prudhomme (SEESIB, UMR 6296, Clermont Ferrand) working on the synthesis of Rebecamycine, Staurosporine and Granulatimide analogues as anticancer agents. He then worked as a post-doctoral fellow with Prof. David. J. Aitken working in the total synthesis of Microsclerodermin C. Following a second post-doctoral fellowship working with Dr. Mouad Alami/ Prof. J.-D. Brion at the Pharmacy Faculty of Châtenay Malabry (Paris Sud University), he was appointed CNRS Researcher (2006) and joined the group of "Therapeutic Chemistry" at the University of Paris 11. He obtained his Habilitation diploma (HDR) in January 2011, working mainly on the transition-metal catalyzed C-C and C-heteroatom bond forming methodologies, and the preparation of molecules and molecular scaffolds of biological and therapeutic interest (Hsp90 inhibitors and vascular disrupting agents).